Alzheimer’s Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)
- 18 August 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 76 (4) , 1541-1551
Abstract
Background: Alzheimer’s disease (AD) is a neurodegenerative condition where the underlying etiology is still unclear. Investigating the potential influence of apolipoprotein E (APOE ), a major genetic risk factor, on common blood biomarkers could proKeywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer DiseaseArchives of Neurology, 2012
- The Insulin-Like Growth Factor System in CancerEndocrinology and Metabolism Clinics of North America, 2012
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Cystatin C in Alzheimer's diseaseFrontiers in Molecular Neuroscience, 2012
- The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysisNeurobiology of Aging, 2011
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer DiseaseArchives of Neurology, 2010
- Worldwide allele frequencies of the human apolipoprotein E gene: Climate, local adaptations, and evolutionary historyAmerican Journal of Physical Anthropology, 2010
- Serum cystatin C and the risk of Alzheimer disease in elderly menNeurology, 2008
- Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's diseaseInternational Psychogeriatrics, 2008
- Serum cholesterol and risk of Alzheimer diseaseNeurology, 2005